gastrointestinal tract acid-446

07/11/2017 - "In the present study, we confirmed the clinical feasibility of GTA-446 as a screening tool for colorectal cancer with a novel measurement system developed for clinical use. "
07/11/2017 - "Thus, GTA-446 is a promising tool for primary colorectal cancer screening to identify populations at a higher risk of colorectal cancer, with an emphasis on early detection."
07/11/2017 - "GTA-446 levels were downregulated in colorectal cancer patients compared with the healthy volunteers, and in females compared with the males in both groups. "
07/11/2017 - "Serum samples were collected from 225 colorectal cancer patients and 916 healthy volunteers to measure GTA-446 levels by flow injection analysis-mass spectrometry. "
07/11/2017 - "Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer."

01/15/2013 - "Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer."